课题基金 / 基金详情

Development of novel therapy and elucidation of pathophysiology for genetic leukodystrophy

Development of novel therapy and elucidation of pathophysiology for genetic leukodystrophy
遗传性脑白质营养不良新疗法的开发和病理生理学的阐明
批准号:
14370252
负责人:
ETO Yoshikatsu
金额:
$9.28万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2004

项目摘要

项目成果

ETO Yoshikatsu的其他基金

相关文献

中文摘要
翻译
我们正在为遗传性脑白质营养不良开发基因和细胞疗法。我们关注的主要疾病是克拉布病。这种疾病是由半乳糖苷酶的遗传缺陷引起的,并且可以获得Krabbe病的真实小鼠模型。使用这种小鼠模型,我们尝试了几种基因治疗方法。首先,我们将携带细菌LacZ基因的腺病毒载体注入正常小鼠胚胎的侧脑室。LacZ表达在整个大脑中观察到,这种表达在出生后持续超过100天。表达LacZ基因的主要细胞类型为神经元和星形胶质细胞。然而,没有少突胶质细胞表达LacZ。虽然这种方法对粘多糖样沉积症VII型小鼠非常有效,但Krabbe病的小鼠模型未能通过这种方法治愈。这种失败可能是由于Krabbe病的主要受累细胞是少突胶质细胞。所以我们测试了逆转录病毒载体而不是腺病毒载体。结果表明,不仅神经元和星形胶质细胞表达LacZ,而且胶质细胞也表达LacZ,并且表达期超过100天,表达量没有明显下降。这一观察结果有力地表明,逆转录病毒载体转染神经干细胞。因此,我们将病毒载体注射到新生小鼠脑室下区,这是已知的许多神经干细胞存在。在这种情况下,主要是星形胶质细胞和少突胶质细胞表达LacZ。由此观察,我们产生了表达半乳糖苷酶的逆转录病毒载体,并将其注射到新生ticker小鼠的脑室下区,这是Krabbe病的真实小鼠模型。逆转录病毒转导可使twitcher小鼠少突软骨细胞的异常形态得到恢复。这表明新生儿基因治疗对Krabbe病神经受累的治疗是可行的。
英文摘要
We are developing gene and cell therapy for genetic leukodystrophies. The main disease, which we focused on, was Krabbe disease. This disease is caused by a genetic deficiency of galactocerebrosidase and the authentic murine model of Krabbe disease is available. Using this murine model, we tried several gene therapy approaches. First, we injected adenoviral vector, which carries bacterial LacZ gene into lateral ventricles of normal mouse embryo. LacZ expression was observed throughout the brain and this expression was persisted more than 100 days after birth. Main cell type, which expressed LacZ gene was neuron and astorocytes. However, no oligodendrocytes expressed LacZ. Although this approach was very effective for mucopolysaccharidosis type VII mice, mouse model of Krabbe disease failed to be cured by this method. This failure may be due that the main affected cell in Krabbe disease is oligodendrocyte. So we tested retroviral vector instead of adenovirus vector. As a result, not only neurons and astrocytes, but also olingodendrocytes expressed LacZ, and the expression period was more than 100 days without significant decrement of expression. This observation strongly indicated that retrovirus vector transdused neural stem cell. So we injected retorovirus vector into subventricular zone of newborn mouse brain, which is known that many neural stem cells exist. In this case, mainly, astorcyte and oligidendrocyte expressed LacZ. From this observation, we generated retrovirus vector which expressed galactocerebrosidase and injected subventricular zone of newborn twitcher mouse, which is authentic mouse model of Krabbe disease. The abnormal morphology of twitcher mouse oligodedrocyte was restored by retrovirus transduction. This indicated that neonatal gene therapy may be feasible for treatment of neural involvement of Krabbe disease.
期刊论文(46)
专著(0)
科研奖励(0)
会议论文
ファブリー病について,ファブリー病
关于法布里病,法布里病
DOI: --
发表时间: 2004
期刊:
影响因子: --
作者: [衛藤義勝, 井田博幸]
通讯作者: 井田博幸
衛藤 義勝: "酵素補充療法の最近の進歩 特集 小児薬物療法に関する最近の話題"小児科. 44・9. 1342-1352 (2003)
Yoshikatsu Eto:“酶替代疗法的最新进展专题:儿科药物治疗的最新主题”儿科学 44・9 (2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Brain transplantation of genetically modified bone marrow stromal cells corrcts CNS pathology and cognitive function in MPS VII mice.
转基因骨髓基质细胞的脑移植可纠正 MPS VII 小鼠的中枢神经系统病理学和认知功能。
DOI: --
发表时间: 2004
期刊: Gene Ther 11(19)
影响因子: --
作者: [Sakurai K, Iizuka S, Shen JS, Meng XL, ori_T, _Umezawa A, Ohashi T, Eto Y]
通讯作者: Eto Y
衛藤 義勝: "Fabry病 特集 小児の疼痛のコントロール"小児内科. 35・8. 1380-1383 (2003)
江藤义胜:“法布里病特刊:儿童疼痛控制”小儿内科 35・8 1380-1383(2003)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 20 条
    Anti-CD3 antibody induced immune tolerance to infused enzyme in enzyme replacement therapy for lysosomal storage disease
    • 批准号:
      21591333
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2009
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Immune tolerance induction in enzyme replacement therapy for lysosomal storage diseases
    • 批准号:
      19591223
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.91万
    • 财政年份:
      2007
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Prenatal Diagnosis of Ingenited Metabolic Disorders Using Maternal Blood
    • 批准号:
      11557061
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $7.1万
    • 财政年份:
      1999
    • 负责人:
      ETO Yoshikatsu
    • 依托单位:
    Molecular Pathogenesis of Brain Damage and Gene Therapy in Genetic Leukodystrophy
    • 批准号:
      11470176
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $9.54万
    • 财政年份:
      1999
    • 负责人:
      ETO Yoshikatsu
    • 依托单位: